Dossier
AI-assisted personalised tumour vaccines
Coverage of AI-assisted personalised tumour vaccines in the Nexus archive.
- China’s first AI-powered cancer vaccine production line set to launch in Beijing
China is launching its first AI-powered production line for personalized cancer vaccines, developed by Beijing-based Likang Life Sciences. The company plans to complete a new drug research and manufacturing center in the Beijing Economic and Technological Development Zone by October, with a 110 million yuan investment.